Search Results
… What is the National Plan to End Parkinson’s? On July 2, 2024, President Biden signed the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End … Plan in the future. Can individuals or organizations set up regular meetings to discuss Parkinson’s research or other …
… On this page What are brain and spinal cord tumors? A tumor is a solid mass … together. Tumors happen when something goes wrong with the genes that manage cell growth, allowing cells to grow and …
… the Grants Management Specialist and Program Officer as soon as possible. Recipients are encouraged to discuss any … institution. This is considered a change of institution, commonly known as a transfer, and requires NINDS prior approval. …
Knowing therapy development is a challenging process, NINDS asked its biologic consultant contractors to generate guidance documents to better prepare investigators.
Image
Protein and Peptide TherapiesGuidance on the preclinical and clinical…
… 301-435-1620 Michelle Victalino joined NINDS in June 2024 as a Grants Management Specialist from the … the Centers for Oceans and Human Health. Her background is in organizational communication and business administration with a B.A. in Communication Studies. … …
… plans or models, parameters, or cut-off values for any disease, modality, or stage of development. Therefore, NINDS …
… on the open and minimally invasive treatment of movement disorders and epilepsy. His current clinical interests …
Scientific Project Manager
Image
Division of Translational Research
Epilepsy Therapy Screening Program (ETSP)
Portfolio: Epilepsy Therapy Screening Program (ETSP), translational and basic science research studies that…
Senior Health Science Policy Analyst
Image
Office of Science Policy & Planning
Contact
sara.dodson@nih.gov…
… 301 480 8219 Kia Brooks is a Regulatory Affairs Specialist in the Clinical Trials Unit (CTU). Ms. Brooks joined NINDS /CTU in October 2019 where she provides regulatory support to the … Physiology from the University of Maryland. She then went on to receive a master’s degree in Clinical Trial Sciences …